The many benefits of patient centricity are widely known, yet many pharma organizations still struggle with implementing the right data-driven approaches that will help them fully achieve it. Improvements in stakeholder engagement, patient collaboration, and timeliness are all possible with your team’s ability to generate insights from a variety of data. This panel of distinguished pharma professionals will discuss the current challenges and recent advancements in providing full, patient-centric care, from clinical research and trials to pre-commercial planning and commercial efficiency. Our panelists specifically focus on oncology patients from early diagnosis to multiple lines of therapies with the goal of detecting and treating patients early.
You will learn: